)
Edge1 May 2026
Making the Marlboro Man
The story of Marlboro's transformation from a women's cigarette to a global icon: one of the most effective brand repositionings in history.
AcuCort
AcuCort (ACUC) investor relations material
AcuCort Q1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 2026 earnings summary28 Apr, 2026
Executive summary
No revenue generated in Q1 2026; net loss after tax was -6,833 KSEK compared to -6,522 KSEK in Q1 2025.
Cash position at period end was 21,153 KSEK.
Signed a commercial agreement with Glenmark Pharmaceuticals for six European countries.
Reached agreement with FDA on iPSP, removing a key regulatory hurdle for US market entry.
Financial highlights
Net loss after tax for Q1 2026 was -6,833 KSEK, slightly higher than -6,522 KSEK in Q1 2025.
Earnings per share before and after dilution was -0.03 SEK, unchanged from Q1 2025.
Cash and cash equivalents at quarter end were 21,153 KSEK, down from 27,012 KSEK at year-end 2025.
Total assets at March 31, 2026, were 62,208 KSEK.
2,150 KSEK in development expenses were capitalized as intangible assets.
Outlook and guidance
Expects increased sales as Zeqmelit® becomes more established in the Nordic market.
Anticipates further regulatory approvals outside the Nordics, with Glenmark planning launches in six European countries in 2027.
Plans to submit a US market application for Zeqmelit® in 2026.
Working to expand into additional European countries and the US, aiming for further revenue growth.
Impact of FDA iPSP on US NDA filing timeline
Strategic role of Germany in Glenmark agreement
Nordic order growth and May 2026 delivery status
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from AcuCort
- Strategic partnerships and capital raise position Zeqmelit® for international expansion despite ongoing losses.ACUC
Q4 202520 Feb 2026 - Losses increased as ZeqmelitⓇ launched in Denmark and global expansion accelerated.ACUCQ3 202514 Nov 2025
- First sales achieved, international expansion underway, and cash position strengthened.ACUCQ2 202519 Aug 2025
- First Zeqmelit® sales recorded; expansion and regulatory progress drive future growth.ACUCQ3 202413 Jun 2025
- ZeqmelitⓇ launch delay led to no H1 revenue, but clinical and regulatory progress remains strong.ACUCQ2 202413 Jun 2025
- No Q1 revenue, but strong capital raise and ZeqmelitⓇ expansion drive future prospects.ACUCQ1 20256 Jun 2025
- First Zeqmelit® sales, widened loss, and SEK 47.7m raised for global expansion.ACUCQ4 20245 Jun 2025
Next AcuCort earnings date
Q2 202619 Aug, 2026
AcuCort
Next AcuCort earnings date
Q2 202619 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage